微RNA:慢性淋巴细胞白血病中潜在的预后和预后生物标志物
Afgar Ali1, Sattarzadeh Bardsiri Mahla2,3, Vahidi Reza1
1Research Center for Hydatid Disease in Iran Kerman University of Medical Sciences Kerman Iran.
EJHaem
|February 26, 2024
概括
微RNAs (miRNAs) 调节基因表达,并与癌症发展有关. 微RNAs的失调在慢性淋巴细胞白血病 (CLL) 中起着关键作用,并影响预后和治疗反应.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 微RNAs (miRNAs) 是小型非编码RNAs,调节基因表达,影响细胞分裂,增殖和死亡.
- 在miRNA结构或功能中的异常可以启动瘤的形成,如慢性淋巴细胞白血病 (CLL) 等癌症中所见.
- 常见的成人白血病CLL涉及缺陷细胞的不受调节的生长,受到遗传变化的显著影响.
研究的目的:
- 审查miRNAs在慢性淋巴细胞白血病 (CLL) 的诊断,预后和治疗中的作用.
- 突出miRNA查对了解CLL病因和发展的重要性.
- 探索针对miRNAs作为CLL的治疗策略的潜力.
主要方法:
- 关于miRNA表达和CLL中的功能研究的文献综述.
- 对表观遗传变化的分析,如甲基化,与CLL进展有关.
- 调查miRNA参与CLL中耐药性机制的研究.
主要成果:
- 在miRNA表达和功能的变化显著影响CLL的发展.
- 在miRNAs的表观遗传变化可以预测CLL疾病的进展和治疗反应.
- 米RNA与CLL中药物耐药性的发展有关.
结论:
- 毫米RNA在CLL的预后中至关重要,并且可以作为疾病进展的生物标志物.
- 向miRNAs为CLL治疗提供了一个有前途的新治疗方法.
- 了解miRNA调节对于推进CLL诊断和管理至关重要.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


